BSE Live
Dec 10, 16:01Prev. Close
750.10
Open Price
755.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 10, 15:53Prev. Close
752.85
Open Price
749.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
779.30 (141)
| Profit & Loss account of Windlas Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | |||||
| Revenue From Operations [Gross] | 755.13 | 628.89 | 510.58 | 463.37 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 755.13 | 628.89 | 510.58 | 463.37 | |
| Total Operating Revenues | 759.88 | 630.96 | 513.08 | 465.93 | |
| Other Income | 18.02 | 13.47 | 9.97 | 6.71 | |
| Total Revenue | 777.90 | 644.42 | 523.05 | 472.64 | |
| EXPENSES | |||||
| Cost Of Materials Consumed | 493.38 | 386.59 | 340.71 | 307.56 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -21.52 | 9.59 | -15.27 | -4.74 | |
| Employee Benefit Expenses | 122.92 | 87.46 | 70.32 | 63.41 | |
| Finance Costs | 4.38 | 1.11 | 0.79 | 1.42 | |
| Depreciation And Amortisation Expenses | 27.99 | 13.44 | 12.36 | 12.15 | |
| Other Expenses | 71.00 | 69.15 | 57.09 | 47.28 | |
| Total Expenses | 698.14 | 567.33 | 466.01 | 427.07 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 79.76 | 77.09 | 57.04 | 45.57 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 79.76 | 77.09 | 57.04 | 45.57 | |
| Tax Expenses-Continued Operations | |||||
| Current Tax | 18.29 | 17.37 | 14.35 | 10.13 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.47 | 1.54 | 0.06 | -2.66 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 18.76 | 18.90 | 14.41 | 7.48 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 60.99 | 58.19 | 42.63 | 38.09 | |
| Profit/Loss From Continuing Operations | 60.99 | 58.19 | 42.63 | 38.09 | |
| Profit/Loss For The Period | 60.99 | 58.19 | 42.63 | 38.09 | |
| Minority Interest | -0.55 | -0.25 | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 60.45 | 57.94 | 42.63 | 38.09 | |
| OTHER ADDITIONAL INFORMATION | |||||
| EARNINGS PER SHARE | |||||
| Basic EPS (Rs.) | 29.00 | 28.00 | 20.00 | 19.00 | |
| Diluted EPS (Rs.) | 29.00 | 28.00 | 20.00 | 19.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||||
| Equity Share Dividend | 11.50 | 8.32 | 7.63 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
12.11.2025
Windlas Biotech Standalone September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
07.11.2025
Windlas Biotech Consolidated September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
10.09.2025
Windlas Biotech Standalone June 2025 Net Sales at Rs 210.09 crore, up 19.95% Y-o-Y
27.05.2025
Windlas Biotech Consolidated March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y
12.11.2025
Windlas Biotech Standalone September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
07.11.2025
Windlas Biotech Consolidated September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
10.09.2025
Windlas Biotech Standalone June 2025 Net Sales at Rs 210.09 crore, up 19.95% Y-o-Y
27.05.2025
Windlas Biotech Consolidated March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y